Injectable long-acting progestogen contraception: A neglected modality
- 1 October 1974
- journal article
- review article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 120 (4) , 537-548
- https://doi.org/10.1016/0002-9378(74)90633-4
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Contraceptive Use—Efficacy Study Utilizing Medroxyprogesterone Acetate Administered As An Intramuscular Injection Once Every 90 DaysFertility and Sterility, 1973
- Contraceptive use — Efficacy study utilizing Depo-Provera® administered as an injection once every six monthsContraception, 1972
- Progestogen treatment of recurrent endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1971
- Effects of depo-medroxyprogesterone acetate as a contraceptive agentAmerican Journal of Obstetrics and Gynecology, 1971
- Contraceptive and endometrial effects of medroxyprogesterone acetateAmerican Journal of Obstetrics and Gynecology, 1969
- Index to advertisersAmerican Journal of Obstetrics and Gynecology, 1967
- Reversible Sterility Induced by Medroxyprogesterone InjectionsFertility and Sterility, 1966
- Progestational Agents in the Treatment of Carcinoma of the EndometriumNew England Journal of Medicine, 1961
- Histological effects of progestins on hyperplasia and carcinoma in situ of the endometriumCancer, 1959
- EFFECTS OF CERTAIN 19-NOR STEROIDS UPON REPRODUCTIVE PROCESSESAnnals of the New York Academy of Sciences, 1958